There are 2789 resources available
308P - FDG-PET/CT versus CE-CT for response monitoring in metastatic breast cancer: A prospective comparative study
Presenter: Marianne Vogsen
Session: ePoster Display
309P - Antineoplastic (ANP) therapies (Tx) after alpelisib (ALP) or placebo (PBO) + fulvestrant (FUL) in patients (Pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), PIK3CA-mutated (Mut) advanced breast cancer (ABC): An analysis from SOLAR-1
Presenter: Fabrice André
Session: ePoster Display
310P - Substantial reduction in the percentage of metastatic breast cancer (MBC) which is HER-2 positive (HER-2+) over two decades: Sequential cohort analysis from the 1000 patient HER-2 study
Presenter: Jose Javier Berenguer-pina
Session: ePoster Display
311P - A global survey of the management of carcinomatous meningitis (CM) in breast cancer patients
Presenter: Evangelia Razis
Session: ePoster Display
365P - The analysis of FGFR-gene family alterations in glioma
Presenter: yunqian Li
Session: ePoster Display
366P - The genetic landscape of tumor predisposition syndromes in Chinese patients with glioma
Presenter: Rutong Yu
Session: ePoster Display
367P - The analysis of STAG2 variants in Chinese adult patients with glioma
Presenter: yongli bo
Session: ePoster Display
368P - Characteristics of deleterious germline mutations in glioma patients
Presenter: Gousiyi Wang
Session: ePoster Display
369P - Characterization of the inflammatory tumor microenvironment composition in brain metastases after failure of immune checkpoint inhibitor therapy
Presenter: Angelika M. Starzer
Session: ePoster Display
370P - Prospective study of apatinib combined with whole brain radiation therapy and simultaneous integrated boost for brain metastases from lung cancer
Presenter: Guang Han
Session: ePoster Display